1p19q-MGMT

Connor J Kinslow1,2, Markus D Siegelin2,3, Fabio M Iwamoto2,4

  • 1Department of Radiation Oncology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, 622 West 168th Street, BNH B011, New York, NY, 10032, USA.

Journal of neuro-oncology
|December 19, 2023
PubMed
概括

对于1p19q-完好无损的形星球细胞瘤,辅助剂temozolomide (TMZ) 仍然是标准的护理,无论O6-甲基瓜氨酸-DNA甲基转移酶 (MGMT) 状态如何. MGMT促进物甲基化是IDH野生型质瘤的关键因素,影响生存结果.